Scarica l'app Stockscreener
10.08
2.52%
-0.2473
Precedente Chiudi:
$10.33
Aprire:
$10.05
Volume 24 ore:
67,804
Relative Volume:
0.39
Capitalizzazione di mercato:
$1.16B
Reddito:
$7.50M
Utile/perdita netta:
$-81.89M
Rapporto P/E:
0.3606
EPS:
27.9585
Flusso di cassa netto:
$-63.58M
1 W Prestazione:
-11.04%
1M Prestazione:
+4.35%
6M Prestazione:
+27.31%
1 anno Prestazione:
+316.12%
Intervallo 1D:
$9.99
$10.15
Intervallo di 1 settimana:
$9.99
$10.98
Portata 52W:
$1.61
$12.18
Mesoblast Ltd Adr Stock (MESO) Company Profile
Nome
Mesoblast Ltd Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta MESO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| MESO | 10.07 | 1.16B | 7.50M | -81.89M | -63.58M | 27.96 |
| VRTX | 446.52 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 741.51 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 589.70 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 250.25 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 103.17 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Mesoblast Ltd Adr Stock (MESO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-09-24 | Aggiornamento | Maxim Group | Hold → Buy |
| 2024-08-29 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-07-23 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-08-31 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-08-07 | Downgrade | Maxim Group | Buy → Hold |
| 2023-08-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-08-04 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-03-09 | Iniziato | William Blair | Outperform |
| 2022-12-06 | Downgrade | Jefferies | Buy → Hold |
| 2022-09-06 | Iniziato | Piper Sandler | Overweight |
| 2021-04-07 | Aggiornamento | Maxim Group | Hold → Buy |
| 2020-12-22 | Downgrade | Maxim Group | Buy → Hold |
| 2020-12-04 | Downgrade | Chardan Capital Markets | Neutral → Sell |
| 2020-10-22 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2020-08-14 | Reiterato | Maxim Group | Buy |
| 2020-05-28 | Reiterato | H.C. Wainwright | Buy |
| 2019-01-31 | Ripresa | H.C. Wainwright | Buy |
| 2018-03-22 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2018-02-28 | Reiterato | Cantor Fitzgerald | Buy |
| 2017-08-31 | Iniziato | Oppenheimer | Outperform |
| 2017-06-08 | Iniziato | Cantor Fitzgerald | Buy |
Mostra tutto
Mesoblast Ltd Adr Borsa (MESO) Ultime notizie
Mesoblast stock soars to 52-week high, hits $11.1 - Investing.com
Mesoblast files annual report and meeting notice - Investing.com India
Mesoblast stock soars to 52-week high, hits $8.7 - Investing.com
Mesoblast Option to Issue Up to US$50 Million Convertible Notes for Product Launch - GlobeNewswire Inc.
Mesoblast stock gains momentum ahead of 2025 PDUFA dateJefferies - Investing.com
The Psychology of Mesoblast Ltd ADR Inc. (MESO) Price Performance: Understanding Market Sentiment - The InvestChronicle
Why Argosy Minerals, Flight Centre, Mesoblast, and Telix shares are sinking today - The Motley Fool
Australia stocks higher at close of trade; S&P/ASX 200 up 0.50% - Investing.com
Up 308% in 6 months, why is the Mesoblast share price tumbling today? - The Motley Fool
Australia stocks higher at close of trade; S&P/ASX 200 up 0.73% - Investing.com
Why Clinuvel, Mesoblast, Red Hill, and Resimac shares are sinking today - The Motley Fool
What's going on with the Mesoblast share price today? - The Motley Fool
Australia stocks higher at close of trade; S&P/ASX 200 up 1.19% By Investing.com - Investing.com
Australia shares higher at close of trade; S&P/ASX 200 up 0.34% - Investing.com India
Australia shares higher at close of trade; S&P/ASX 200 up 1.01% - Investing.com India
Mesoblast LtdADR (MESO) Price Target Increased by 5.79% to 1.56 - MSN
There is no doubt that Mesoblast Ltd ADR (MESO) ticks all the boxes. – Sete News - SETE News
Australia stocks higher at close of trade; S&P/ASX 200 up 0.81% - Investing.com
Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners - Stockhead
Australia stocks lower at close of trade; S&P/ASX 200 down 0.09% By Investing.com - Investing.com
Mesoblast Limited: Back From The Dead (NASDAQ:MESO) - Seeking Alpha
Australia stocks higher at close of trade; S&P/ASX 200 up 0.99% - Investing.com
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Benzinga
11 Best ASX Stocks To Buy Now - Yahoo Finance
Australia stocks higher at close of trade; S&P/ASX 200 up 0.11% By Investing.com - Investing.com
Australia stocks higher at close of trade; S&P/ASX 200 up 0.39% By Investing.com - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
10 Best Australian Stocks To Buy - Yahoo Finance
Mesoblast Stock Set to Reverse Split on Friday, January 5th (NASDAQ:MESO) - MarketBeat
Top Penny Stocks for Q3 2023 - Investopedia
Here’s why Mesoblast shares are in a trading halt today - The Motley Fool Australia
Class action proposed against biotech Mesoblast after historic collapse in share price - Business News Australia
The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data - Benzinga
41 Stocks Moving in Friday's Pre-Market SessionAmarin Corp (NASDAQ:AMRN), Artelo Biosciences (NASDAQ:A - Benzinga
The Daily Biotech Pulse: Mesoblast Slumps On FDA Rejection, AstraZeneca's Breakthrough Therapy Designation, 3 IPOs - Yahoo Finance
The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Sh - Benzinga
The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rock - Benzinga
The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares - Yahoo Finance
The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves I - Benzinga
The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger - Yahoo Finance
The Daily Biotech Pulse: Mylan Recalls Blood Pressure Drug, Heat Biologics Offering, New Novelion CEOi - Benzinga
Mesoblast's Delayed Launches, Teva Split Turn Credit Suisse BearishMesoblast (NASDAQ:MESO) - Benzinga
12 Biggest Mid-Day Losers For ThursdayAvalon Holdings (AMEX:AWX) - Benzinga
Exclusive Interview With Pluristem Therapeutics Inc.(NASDAQ:PSTI) President Yaky Yanay - Market Exclusive
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) On Track to Becoming Largest Generics Manufacturer - The Wall Street Transcript
Advantage: Australia. Biotechs Surge Ahead in Regenerative Medicine and Immuno-Oncology - Streetwise Reports
Mesoblast Ltd Adr Azioni (MESO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.42%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):